← All patents

US20160058889A1

Prevention of muscular dystrophy by crispr/cas9-mediated gene editing

University of Texas System

Abstract

Duchenne muscular dystrophy (DMD) is an inherited X-linked disease caused by mutations in the gene encoding dystrophin, a protein required for muscle fiber integrity. The disclosure reports CRISPR/Cas9-mediated gene editing (Myo-editing) is effective at correcting the dystrophin gene mutation in …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Eric N. Olson
Priority date
August 11, 2014
Filing date
August 11, 2015
Publication date
March 03, 2016
Language
en
Metadata fetched
August 29, 2026 00:23